Literature DB >> 11844744

Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

Antonio C Bianco1, Domenico Salvatore, Balázs Gereben, Marla J Berry, P Reed Larsen.   

Abstract

The goal of this review is to place the exciting advances that have occurred in our understanding of the molecular biology of the types 1, 2, and 3 (D1, D2, and D3, respectively) iodothyronine deiodinases into a biochemical and physiological context. We review new data regarding the mechanism of selenoprotein synthesis, the molecular and cellular biological properties of the individual deiodinases, including gene structure, mRNA and protein characteristics, tissue distribution, subcellular localization and topology, enzymatic properties, structure-activity relationships, and regulation of synthesis, inactivation, and degradation. These provide the background for a discussion of their role in thyroid physiology in humans and other vertebrates, including evidence that D2 plays a significant role in human plasma T(3) production. We discuss the pathological role of D3 overexpression causing "consumptive hypothyroidism" as well as our current understanding of the pathophysiology of iodothyronine deiodination during illness and amiodarone therapy. Finally, we review the new insights from analysis of mice with targeted disruption of the Dio2 gene and overexpression of D2 in the myocardium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844744     DOI: 10.1210/edrv.23.1.0455

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  413 in total

Review 1.  The distribution and mechanism of iodotyrosine deiodinase defied expectations.

Authors:  Zuodong Sun; Qi Su; Steven E Rokita
Journal:  Arch Biochem Biophys       Date:  2017-07-31       Impact factor: 4.013

2.  A switch between one- and two-electron chemistry of the human flavoprotein iodotyrosine deiodinase is controlled by substrate.

Authors:  Jimin Hu; Watchalee Chuenchor; Steven E Rokita
Journal:  J Biol Chem       Date:  2014-11-13       Impact factor: 5.157

3.  Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.

Authors:  Mitsuhiro Watanabe; Yasushi Horai; Sander M Houten; Kohkichi Morimoto; Taichi Sugizaki; Eri Arita; Chikage Mataki; Hiroyuki Sato; Yusuke Tanigawara; Kristina Schoonjans; Hiroshi Itoh; Johan Auwerx
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

4.  Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians.

Authors:  Saraswathy Nair; Yunhua Li Muller; Emilio Ortega; Sayuko Kobes; Clifton Bogardus; Leslie J Baier
Journal:  Thyroid       Date:  2011-12-05       Impact factor: 6.568

Review 5.  Ubiquitinated deiodinase: not dead yet.

Authors:  Ronald J Koenig
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

6.  Endoplasmic reticulum stress decreases intracellular thyroid hormone activation via an eIF2a-mediated decrease in type 2 deiodinase synthesis.

Authors:  Rafael Arrojo E Drigo; Tatiana L Fonseca; Melany Castillo; Matthias Salathe; Gordana Simovic; Petra Mohácsik; Balazs Gereben; Antonio C Bianco
Journal:  Mol Endocrinol       Date:  2011-11-03

Review 7.  Endocrine mechanisms of seasonal adaptation in small mammals: from early results to present understanding.

Authors:  Frank Scherbarth; Stephan Steinlechner
Journal:  J Comp Physiol B       Date:  2010-07-17       Impact factor: 2.200

8.  Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry.

Authors:  Dongli Wang; Heather M Stapleton
Journal:  Anal Bioanal Chem       Date:  2010-05-01       Impact factor: 4.142

9.  Sex differences in gene expression in response to ischemia in the human left ventricular myocardium.

Authors:  Gregory Stone; Ashley Choi; Oliva Meritxell; Joshua Gorham; Mahyar Heydarpour; Christine E Seidman; Jon G Seidman; Sary F Aranki; Simon C Body; Vincent J Carey; Benjamin A Raby; Barbara E Stranger; Jochen D Muehlschlegel
Journal:  Hum Mol Genet       Date:  2019-05-15       Impact factor: 6.150

Review 10.  The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.

Authors:  Charles E Schwartz; Roger E Stevenson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-06       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.